Results 31 to 40 of about 247,168 (212)

CD44-targeted near-infrared photoimmunotherapy shows potent anti-tumor effects in an orthotopic lung cancer model [PDF]

open access: yesBMC Cancer
Background Lung cancer continues to be associated with a dismal prognosis, despite the recent development of multiple therapeutic modalities. Consequently, there remains an urgent need for the advancement of novel and more efficacious treatment ...
Hiroshi Yamasaki   +11 more
doaj   +2 more sources

Synergistic nanotheranostic platform for fluorescence/magnetic resonance bimodal imaging-guided near infrared photoimmuno-chemodynamic thermal targeting therapy [PDF]

open access: yesJournal of Nanobiotechnology
Near-infrared (NIR) photoimmunotherapy (PIT) is a promising cancer treatment strategy involving antibody–photoabsorber conjugates. However, the imaging depth and photobleaching susceptibility of the IR700 fluorescence used for treatment monitoring are ...
Kohei Matsuoka   +14 more
doaj   +2 more sources

NIR-PIT: Will It Become a Standard Cancer Treatment? [PDF]

open access: yesFrontiers in Oncology, 2022
Aki Furusawa   +2 more
exaly   +2 more sources

Therapeutic potential of photoimmunotherapy in solid tumors expressing CD98 heavy chain [PDF]

open access: yesScientific Reports
Near-infrared photoimmunotherapy (NIR-PIT) is an emerging targeted cancer therapy that uses an antibody–photoabsorber conjugate. In this study, we evaluated the therapeutic potential of NIR-PIT targeting CD98 heavy chain (CD98hc), a transmembrane ...
Citra R. A. P. Palangka   +3 more
doaj   +2 more sources

Development of a Peptide-Based Photoimmunotherapy Drug Targeting PD-L1 [PDF]

open access: yesMolecules
Near-infrared photoimmunotherapy (NIR-PIT) has recently attracted attention as a highly selective cancer treatment, with good treatment outcomes observed from the only antibody-based drug currently available for clinical use. However, since only a single
Takuya Otani   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy